DYN
Dyne Therapeutics, Inc. NASDAQ Listed Sep 17, 2020$17.54
Mkt Cap $2.9B
52w Low $8.06
56.0% of range
52w High $25.00
50d MA $18.02
200d MA $16.69
P/E (TTM)
-5.0x
EV/EBITDA
-3.7x
P/B
2.3x
Debt/Equity
0.0x
ROE
-45.9%
P/FCF
-6.2x
RSI (14)
—
ATR (14)
—
Beta
1.28
50d MA
$18.02
200d MA
$16.69
Avg Volume
2.1M
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
1560 Trapelo Road · Waltham, MA 02451 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | BMO | — | — | — | 17.54 | -0.3% | +0.4% | — | — | — | — | — |
| May 7, 2026 | BMO | — | — | — | 18.84 | +0.1% | -6.9% | — | — | — | — | — |
| Mar 2, 2026 | AMC | -0.74 | -0.76 | -2.7% | 16.15 | -4.1% | -9.6% | -5.7% | -5.9% | -8.0% | +9.5% | — |
| Nov 5, 2025 | AMC | -0.81 | -0.76 | +6.2% | 20.90 | +0.8% | -12.9% | -12.2% | -11.4% | -5.9% | -11.0% | — |
| Jul 28, 2025 | AMC | -0.99 | -0.97 | +2.0% | 9.31 | +2.0% | -1.2% | +6.4% | +5.8% | +7.9% | +10.1% | — |
| May 8, 2025 | AMC | -0.88 | -1.05 | -19.3% | 11.30 | +1.2% | +1.0% | +11.2% | +7.1% | +3.5% | +3.9% | — |
| Feb 27, 2025 | AMC | -0.92 | -0.88 | +4.3% | 13.17 | -0.5% | +3.3% | -6.5% | -9.7% | -7.5% | -7.1% | — |
| Nov 12, 2024 | AMC | -0.71 | -0.96 | -35.2% | 29.33 | -0.7% | +16.4% | +3.3% | -3.2% | +0.0% | +1.2% | — |
| Aug 12, 2024 | AMC | -0.72 | -0.70 | +2.8% | 43.07 | +2.7% | +1.3% | +1.9% | +6.2% | +5.4% | +7.1% | — |
| May 2, 2024 | AMC | -0.81 | -0.81 | +0.0% | 26.00 | +0.0% | +0.3% | +1.0% | -1.3% | -1.2% | -0.2% | — |
| Mar 5, 2024 | AMC | -0.92 | -1.09 | -18.5% | 25.87 | +4.3% | +3.5% | +2.2% | -2.7% | -1.2% | +4.8% | — |
| Oct 30, 2023 | AMC | -0.86 | -0.99 | -15.1% | 7.32 | -1.8% | -3.7% | -0.3% | -2.3% | +12.4% | +11.5% | — |
| Aug 3, 2023 | AMC | -0.81 | -1.08 | -33.3% | 11.50 | -0.8% | +0.4% | +0.5% | -13.7% | -8.0% | -5.0% | — |
| May 11, 2023 | AMC | -0.77 | -0.78 | -1.3% | 13.60 | +0.4% | -1.2% | +0.7% | -1.8% | -0.2% | -3.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9 | Chardan Capital | Maintains | Buy → Buy | — | $14.86 | $15.27 | +2.8% | +19.0% | +33.1% | +34.5% | +21.5% | +20.6% |
| Mar 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $16.15 | $15.49 | -4.1% | -9.6% | -5.7% | -5.9% | -8.0% | +9.5% |
| Mar 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.15 | $15.49 | -4.1% | -9.6% | -5.7% | -5.9% | -8.0% | +9.5% |
| Mar 3 | Chardan Capital | Maintains | Buy → Buy | — | $16.15 | $15.49 | -4.1% | -9.6% | -5.7% | -5.9% | -8.0% | +9.5% |
| Jan 20 | JP Morgan | Maintains | Neutral → Neutral | — | $16.70 | $16.52 | -1.1% | -0.7% | +4.8% | +8.3% | +7.8% | +7.8% |
| Dec 15 | Evercore ISI | Maintains | Outperform → Outperform | — | $19.27 | $19.31 | +0.2% | +1.7% | +1.5% | -1.9% | -3.7% | +3.0% |
| Dec 11 | Stifel | Maintains | Buy → Buy | — | $19.69 | $20.05 | +1.8% | -1.4% | -2.1% | -0.5% | -0.7% | -4.0% |
| Dec 10 | Oppenheimer | Upgrade | Perform → Outperform | — | $18.44 | $19.57 | +6.1% | +6.8% | +5.3% | +4.5% | +6.2% | +6.0% |
| Dec 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $22.20 | $21.41 | -3.6% | -16.9% | -11.3% | -12.5% | -13.2% | -11.8% |
| Dec 9 | Chardan Capital | Maintains | Buy → Buy | — | $22.20 | $21.41 | -3.6% | -16.9% | -11.3% | -12.5% | -13.2% | -11.8% |
| Dec 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.28 | $21.59 | +6.5% | +9.5% | -9.1% | -2.9% | -4.2% | -5.0% |
| Nov 14 | JP Morgan | Maintains | Neutral → Neutral | — | $18.83 | $18.34 | -2.6% | -0.2% | +7.5% | +11.3% | +9.4% | +6.9% |
| Nov 12 | Oppenheimer | Maintains | Perform → Perform | — | $19.67 | $19.41 | -1.3% | -5.4% | -4.3% | -4.5% | +2.9% | +6.6% |
| Nov 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.90 | $21.06 | +0.8% | -12.9% | -12.2% | -11.4% | -5.9% | -11.0% |
| Nov 6 | RBC Capital | Maintains | Outperform → Outperform | — | $20.90 | $21.06 | +0.8% | -12.9% | -12.2% | -11.4% | -5.9% | -11.0% |
| Oct 10 | Oppenheimer | Downgrade | Outperform → Perform | — | $14.68 | $14.13 | -3.7% | -4.3% | -4.4% | +5.2% | +12.6% | +11.9% |
| Aug 25 | Raymond James | Upgrade | Outperform → Strong Buy | — | $12.58 | $13.55 | +7.7% | +3.3% | +6.4% | +8.4% | +9.3% | +7.2% |
| Aug 6 | Oppenheimer | Maintains | Outperform → Outperform | — | $10.47 | $10.23 | -2.3% | +10.7% | +6.9% | +6.6% | +7.4% | +11.0% |
| Jul 31 | Stifel | Maintains | Buy → Buy | — | $9.91 | $9.80 | -1.1% | -0.6% | +1.4% | +3.4% | +5.7% | +17.0% |
| Jul 29 | Chardan Capital | Maintains | Buy → Buy | — | $9.31 | $9.50 | +2.0% | -1.2% | +6.4% | +5.8% | +7.9% | +10.1% |
| Jul 29 | Raymond James | Maintains | Outperform → Outperform | — | $9.31 | $9.50 | +2.0% | -1.2% | +6.4% | +5.8% | +7.9% | +10.1% |
| Jul 29 | RBC Capital | Maintains | Outperform → Outperform | — | $9.31 | $9.50 | +2.0% | -1.2% | +6.4% | +5.8% | +7.9% | +10.1% |
| Jul 15 | JP Morgan | Maintains | Neutral → Neutral | — | $8.91 | $9.04 | +1.5% | -7.1% | +4.7% | +5.5% | +1.2% | +2.9% |
| Jun 18 | Baird | Maintains | Outperform → Outperform | — | $10.86 | $10.79 | -0.6% | -0.7% | -5.0% | -6.4% | -2.1% | -4.1% |
| Jun 18 | Guggenheim | Maintains | Buy → Buy | — | $10.86 | $10.79 | -0.6% | -0.7% | -5.0% | -6.4% | -2.1% | -4.1% |
| Jun 17 | Chardan Capital | Maintains | Buy → Buy | — | $13.82 | $12.51 | -9.5% | -21.4% | -22.0% | -25.3% | -26.5% | -23.1% |
| May 9 | Chardan Capital | Maintains | Buy → Buy | — | $11.30 | $11.44 | +1.2% | +1.0% | +11.2% | +7.1% | +3.5% | +3.9% |
| May 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.30 | $11.44 | +1.2% | +1.0% | +11.2% | +7.1% | +3.5% | +3.9% |
| Mar 21 | JP Morgan | Maintains | Neutral → Neutral | — | $12.26 | $12.14 | -1.0% | -1.5% | +1.1% | -7.0% | -8.2% | -3.8% |
| Mar 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.05 | $12.46 | +3.4% | +2.2% | +4.4% | +2.9% | +1.7% | +0.2% |
| Mar 17 | Chardan Capital | Maintains | Buy → Buy | — | $12.05 | $12.46 | +3.4% | +2.2% | +4.4% | +2.9% | +1.7% | +0.2% |
| Feb 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $13.17 | $13.10 | -0.5% | +3.3% | -6.5% | -9.7% | -7.5% | -7.1% |
| Feb 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.17 | $13.10 | -0.5% | +3.3% | -6.5% | -9.7% | -7.5% | -7.1% |
| Feb 28 | Chardan Capital | Maintains | Buy → Buy | — | $13.17 | $13.10 | -0.5% | +3.3% | -6.5% | -9.7% | -7.5% | -7.1% |
| Jan 24 | Guggenheim | Maintains | Buy → Buy | — | $13.69 | $13.72 | +0.2% | +0.2% | -0.1% | -1.7% | -1.1% | +3.3% |
| Jan 14 | RBC Capital | Maintains | Outperform → Outperform | — | $15.29 | $15.75 | +3.0% | -1.9% | +1.6% | -3.4% | -7.6% | -4.8% |
| Jan 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $15.87 | $15.80 | -0.4% | -3.7% | -5.5% | -2.1% | -6.9% | -11.0% |
| Jan 10 | Chardan Capital | Maintains | Buy → Buy | — | $23.05 | $20.00 | -13.2% | -31.1% | -33.7% | -34.9% | -32.6% | -35.9% |
| Jan 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.05 | $20.00 | -13.2% | -31.1% | -33.7% | -34.9% | -32.6% | -35.9% |
| Nov 13 | Chardan Capital | Maintains | Buy → Buy | — | $29.33 | $29.12 | -0.7% | +16.4% | +3.3% | -3.2% | +0.0% | +1.2% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $29.33 | $29.12 | -0.7% | +16.4% | +3.3% | -3.2% | +0.0% | +1.2% |
| Oct 24 | JP Morgan | Downgrade | Overweight → Neutral | — | $32.36 | $31.33 | -3.2% | -3.9% | -5.0% | -4.9% | -6.6% | -9.8% |
| Sep 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $36.59 | $36.64 | +0.1% | -5.4% | -8.7% | -4.7% | -5.4% | -7.5% |
| Sep 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $31.94 | $31.88 | -0.2% | +5.7% | +5.4% | +3.4% | +1.7% | +1.5% |
| Sep 3 | Oppenheimer | Maintains | Outperform → Outperform | — | $46.09 | $27.77 | -39.7% | -30.7% | -26.8% | -27.0% | -28.3% | -29.6% |
| Aug 16 | Stifel | Maintains | Buy → Buy | — | $45.74 | $45.36 | -0.8% | -0.8% | +0.8% | +2.4% | +2.8% | -0.5% |
| Aug 15 | Guggenheim | Maintains | Buy → Buy | — | $43.88 | $45.01 | +2.6% | +4.2% | +3.4% | +5.1% | +6.7% | +7.2% |
| Aug 14 | Morgan Stanley | Maintains | Overweight → Overweight | — | $43.64 | $43.89 | +0.6% | +0.6% | +4.8% | +4.0% | +5.7% | +7.3% |
| Aug 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $43.07 | $44.24 | +2.7% | +1.3% | +1.9% | +6.2% | +5.4% | +7.1% |
| Aug 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $43.07 | $44.24 | +2.7% | +1.3% | +1.9% | +6.2% | +5.4% | +7.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | Rhodes Jason P | — | Sell | 17,244 | $18.18 | $313K | 1,136,810 | -6.90% | — |
| May 6, 2026 | Rhodes Jason P | — | Sell | 428 | $18.18 | $8K | 7,962 | -6.90% | — |
| May 6, 2026 | Rhodes Jason P | — | Sell | 43,621 | $18.18 | $793K | 4,883,494 | -6.90% | — |
| May 6, 2026 | Rhodes Jason P | — | Sell | 21,926 | $18.18 | $399K | 1,549,288 | -6.90% | — |
| May 5, 2026 | Rhodes Jason P | — | Sell | 2,403 | $18.03 | $43K | 1,154,054 | -6.90% | — |
| May 5, 2026 | Rhodes Jason P | — | Sell | 60 | $18.03 | $1K | 8,390 | -6.90% | — |
| May 5, 2026 | Rhodes Jason P | — | Sell | 6,081 | $18.03 | $110K | 4,927,115 | -6.90% | — |
| May 5, 2026 | Rhodes Jason P | — | Sell | 3,056 | $18.03 | $55K | 1,571,214 | -6.90% | — |
| May 4, 2026 | Rhodes Jason P | — | Sell | 2,466 | $18.00 | $44K | 1,156,457 | -6.90% | — |
| May 4, 2026 | Rhodes Jason P | — | Sell | 61 | $18.00 | $1K | 8,450 | -6.90% | — |
| May 4, 2026 | Rhodes Jason P | — | Sell | 6,241 | $18.00 | $112K | 4,933,196 | -6.90% | — |
| May 4, 2026 | Rhodes Jason P | — | Sell | 3,136 | $18.00 | $56K | 1,574,270 | -6.90% | — |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 21 | $19.00 | $399 | 1,158,923 | -0.91% | -0.06% |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 1 | $19.00 | $19 | 8,511 | -0.91% | -0.06% |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 52 | $19.00 | $988 | 4,939,437 | -0.91% | -0.06% |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 26 | $19.00 | $494 | 1,577,406 | -0.91% | -0.06% |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 47,082 | $18.38 | $865K | 1,158,944 | -0.91% | -0.06% |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 1,170 | $18.38 | $22K | 8,512 | -0.91% | -0.06% |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 119,115 | $18.38 | $2.2M | 4,939,489 | -0.91% | -0.06% |
| Apr 28, 2026 | Rhodes Jason P | — | Sell | 59,870 | $18.38 | $1.1M | 1,577,432 | -0.91% | -0.06% |
| Apr 27, 2026 | Rhodes Jason P | — | Sell | 35,947 | $18.15 | $652K | 1,206,026 | +0.67% | -1.83% |
| Apr 27, 2026 | Rhodes Jason P | — | Sell | 894 | $18.15 | $16K | 9,682 | +0.67% | -1.83% |
| Apr 27, 2026 | Rhodes Jason P | — | Sell | 90,943 | $18.15 | $1.7M | 5,058,604 | +0.67% | -1.83% |
| Apr 27, 2026 | Rhodes Jason P | — | Sell | 45,709 | $18.15 | $830K | 1,637,302 | +0.67% | -1.83% |
| Apr 24, 2026 | Rhodes Jason P | — | Sell | 28,583 | $18.48 | $528K | 1,241,973 | +0.67% | -1.83% |
| Apr 24, 2026 | Rhodes Jason P | — | Sell | 710 | $18.48 | $13K | 10,576 | +0.67% | -1.83% |
| Apr 24, 2026 | Rhodes Jason P | — | Sell | 72,310 | $18.48 | $1.3M | 5,149,547 | +0.67% | -1.83% |
| Apr 24, 2026 | Rhodes Jason P | — | Sell | 36,345 | $18.48 | $672K | 1,683,011 | +0.67% | -1.83% |
| Apr 23, 2026 | Rhodes Jason P | — | Sell | 15,148 | $19.19 | $291K | 1,270,556 | +0.67% | -1.83% |
| Apr 23, 2026 | Rhodes Jason P | — | Sell | 377 | $19.19 | $7K | 11,286 | +0.67% | -1.83% |
Data updated apr 25, 2026 6:12am
· Source: massive.com